Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin

This publication has 47 references indexed in Scilit:

• Allele-Selective Inhibition of Huntingtin Expression by Switching to an miRNA-like RNAi Mechanism
  Published by Elsevier ,2010
• Allele-Selective Inhibition of Mutant Huntingtin Expression with Antisense Oligonucleotides Targeting the Expanded CAG Repeat
  Biochemistry, 2010
• Huntington's disease: Silencing a brutal killer
  Experimental Neurology, 2009
• Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
  Molecular Therapy, 2009
• Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease Patients
  Current Biology, 2009
• Sustained effects of nonallele‐specific Huntingtin silencing
  Annals of Neurology, 2009
• A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference
  Experimental Neurology, 2009
• CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing Haplogroup
  American Journal of Human Genetics, 2009
• Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice
  Molecular Therapy, 2005
• Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion
  Nature Genetics, 1997